risedronic acid has been researched along with imatinib mesylate in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sparrowhawk, M; Steele, P | 1 |
| Buś-Kwaśnik, K; Kaza, M; Rudzki, PJ | 1 |
| Biecek, P; Kaza, M; Rudzki, PJ | 1 |
3 other study(ies) available for risedronic acid and imatinib mesylate
| Article | Year |
|---|---|
Patent news.
Topics: Animals; Antineoplastic Agents; Benzamides; Carbazoles; Drug Industry; Etidronic Acid; Gastroesophageal Reflux; Humans; Imatinib Mesylate; Patents as Topic; Piperazines; Pyrimidines; Risedronic Acid; Serotonin Receptor Agonists; Tryptamines; United Kingdom | 2003 |
Incurred sample reanalysis: adjusted procedure for sample size calculation.
Topics: Chromatography, High Pressure Liquid; Humans; Imatinib Mesylate; Models, Theoretical; Risedronic Acid; Specimen Handling; Spectrophotometry, Ultraviolet; Tandem Mass Spectrometry | 2017 |
Extended 3D and 4D cumulative plots for evaluation of unmatched incurred sample reanalysis.
Topics: Analysis of Variance; Antihypertensive Agents; Antineoplastic Agents; Bone Density Conservation Agents; Computer Graphics; Datasets as Topic; Humans; Imatinib Mesylate; Imidazoles; Reproducibility of Results; Risedronic Acid; Tetrazoles | 2018 |